Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 12/20 | 0.52 |
| ▸ | CTSV | O60911 | 11/20 | 0.52 |
| ▸ | CTSS | P25774 | 11/20 | 0.52 |
| ▸ | CTSB | P07858 | 8/20 | 0.52 |
| ▸ | CTSK | P43235 | 8/20 | 0.52 |
| ▸ | PNMT | P11086 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | FPR2 | P25090 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL805207 | 1.00 | CTSL (0.52) | CTSLCTSVCTSSCTSBCTSK | |
| SCHEMBL16287362 | 1.00 | CTSL (0.52) | CTSLCTSVCTSSCTSBCTSK | |
| SCHEMBL29539732 | 1.00 | CTSL (0.52) | CTSLCTSVCTSSCTSBCTSK | |
| Hydrochloric Acid SCHEMBL16289133 | 0.98 | CTSL (0.51) | CTSLCTSVCTSSCTSBCTSK | |
| SCHEMBL14898396 | 0.88 | PNMT (0.51) | CTSLCTSVCTSSCTSBCTSK | |
| SCHEMBL14942915 | 0.88 | PNMT (0.51) | CTSLCTSVCTSSCTSBCTSK | |
| SCHEMBL21837394 | 0.85 | TAAR1 (0.51) | MAPK1FOLH1TAAR1 | |
| SCHEMBL21837393 | 0.85 | TAAR1 (0.51) | MAPK1FOLH1TAAR1 | |
| SCHEMBL23901512 | 0.85 | PNMT (0.53) | CTSLCTSVCTSSCTSBCTSK | |
| SCHEMBL11134765 | 0.85 | CTSL (0.50) | CTSLCTSVCTSSCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | CTSL 3190/4885CTSV 4327/4885CTSS 4675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.